Skip to main content

Grown Rogue International Inc.

For the period ended Jun 30, 2026. Filed Aug 5, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 5, 2026

GRUSFStored price and day change unavailable

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows

Condensed Consolidated Statements of Changes in Cash Flows

For the six months ended June 30, 2026 and 2025

(Expressed in United States Dollars, unless otherwise indicated) - Unaudited

20262025
$$
Operating activities
Net income (loss)(3,694,415)2,398,248
Adjustments for non-cash items in net income (loss) and earnings impact of warrant liability reclassification:
Depreciation of property and equipment156,812212,911
Depreciation of property and equipment included in costs of finished cannabis inventory sold1,577,038795,337
Lease costs included in costs of finished cannabis inventory sold542,497927,805
Share-based compensation304,0811,772,735
Interest and accretion expense979,220690,724
Other income-(5,251)
Interest income(84,844)(72,274)
Unrealized (gain) loss on derivative liability(148,383)27,654
Realized (gain) loss on derivative liability-(5,859,744)
Unrealized loss on warrant asset2,747,6671,340,654
Unrealized gain on warrant liability(433,547)-
Loss on equity investment in associate293,250268,420
Deferred income taxes(272,243)(55,184)
Changes in operating assets and liabilities (Note 18)2,280,732(3,098,916)
Net cash provided by (used in) operating activities4,247,865(656,881)
Investing activities
Purchase of property and equipment(5,498,773)(241,532)
Payments of business acquisition consideration payable(377,988)(254,828)
Investment in Rogue EBC, LLC equity interest(415,000)(468,000)
Net cash used in investing activities(6,291,761)(964,360)
Financing activities
Sale of non-controlling interest in GRMA, net of issuance costs2,985,000-
Proceeds from exercise of stock options21,839402,844
Proceeds from long-term debt1,000,0007,471,063
Distributions to non-controlling interests in subsidiaries(235,156)(70,000)
Debt issuance costs-(246,913)
Repayment of long-term debt(1,529,295)(1,169,064)
Payment of interest on convertible debentures-(79,755)
Repayment of finance lease(37,500)(6,250)
Net cash provided by financing activities2,204,8886,301,925
Effect of foreign exchange on cash and cash equivalents-1,285
Change in cash and cash equivalents160,9924,681,969
Cash and cash equivalents, beginning of period11,371,8344,917,708
Cash and cash equivalents, end of period11,532,8269,599,677
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.